16 avril, 2008 14:07
New York News
______________________________________________________________
Panel’s Bipartisan View: F.D.A. Is Underfinanced - New York Times
Merck Wrote Drug Studies for Doctors
Ghostwriters Used in Vioxx Studies, Article Says
Canada Likely to Label Plastic Ingredient ‘Toxic’ - New York Times
http://www.nytimes.com/2008/04/14/us/14drug.html
Co-Payments Soar for Drugs With High Prices
Fewer Large Corporations Audited by IRS - New York Times Why not and taxed instead of us?
To Cut or What? The World Butts In- breast implants- angry response from persons New York Times
Citing Ethics, Some Doctors Are Rejecting Industry Pay - New York Times
With little fanfare, a small number of prominent academic scientists have made a decision that was until recently all but unheard of. They decided to stop accepting payments from food, drug and medical device companies.
No longer will they be paid for speaking at meetings or for sitting on advisory boards. They may still work with companies. It is important, they say, for knowledgeable scientists to help companies draw up and interpret studies. But the work will be pro bono. read the rest, I found this quite interesting.
Gigi-Karen
Bottle Maker to Stop Using Plastic Linked to Health Concerns - New York Times
